A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

(2013) David Ternant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms

(2012) I Ordás et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Changes of the cytokine profile in inflammatory bowel diseases

(2012) Györgyi Műzes   WORLD JOURNAL OF GASTROENTEROLOGY

Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

(2011) David Ternant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13R 2

(2011) M. T. Kasaian et al.   JOURNAL OF IMMUNOLOGY

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

(2010) Nathanael L. Dirks et al.   CLINICAL PHARMACOKINETICS

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

(2009) Adedigbo A. Fasanmade et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

IL-13 as a therapeutic target for respiratory disease

(2008) Marion T. Kasaian et al.   BIOCHEMICAL PHARMACOLOGY

Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

(2008) Zhenhua Xu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys

(2008) M. T. Kasaian et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS